← Back
$JANX All transactions

Janux Therapeutics, Inc.

A

$ Value

$0

Shares

36,000

Price

$0

Filed

Jan 2

Insider

Name

Doyle Janeen Noel

Title

Chief Corp. & Bus. Dev. Ofcr

CIK

0002069239

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

80,000

Footnotes

Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027. | 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

Filing Info

Accession No.

0002069239-26-000002

Form Type

4

Issuer CIK

0001817713

Doyle Janeen Noel's History

Date Ticker Type Value
2026-01-02 JANX A $0
2026-01-02 JANX A $0
2025-06-02 JANX A $0
2025-06-02 JANX A $0

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02